PO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
AffiliationInstitute of Cancer Sciences, University of Manchester; Department of Academic Surgery, University Hospital of South Manchester
MetadataShow full item record
AbstractCirculating tumour cells (CTCs) are a marker of poor prognosis and are associated with increased risk of venous thromboembolism in metastatic breast cancer.
CitationPO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer. 2016, 140 Suppl 1:S188 Thromb Res
- Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
- Authors: Kirwan CC, Descamps T, Castle J
- Issue date: 2020 Jun
- Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.
- Authors: Mego M, Zuo Z, Gao H, Cohen EN, Giordano A, Tin S, Anfossi S, Jackson S, Woodward W, Ueno NT, Valero V, Alvarez RH, Hortobagyi GN, Khoury JD, Cristofanilli M, Reuben JM
- Issue date: 2015 Mar
- Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion.
- Authors: Shaker H, Bundred NJ, Landberg G, Pritchard SA, Albadry H, Nicholson SL, Harries LJ, Heah JYE, Castle J, Kirwan CC
- Issue date: 2020 Mar
- Evaluation of analytic and clinical performance of thrombin-antithrombin complex and D-dimer assay in prognosis of acute ischemic stroke.
- Authors: Ye N, Liu Z, Wang X, Xu X, Wu W
- Issue date: 2020 Jul
- Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
- Authors: Bailey MA, Griffin KJ, Sohrabi S, Whalley DJ, Johnson AB, Baxter PD, Ariëns RA, Scott DJ
- Issue date: 2013 Jun